Norway vaccine side-effects to 11th May 2021 (Note: The Astrazeneca Vaxevria vaccine is no longer used in Norway)
Princess Michael of Kent is being treated for blood clots after receiving two doses of the Oxford/AstraZeneca vaccine – although no link has been established. Sources close to the 76-year-old said concerns for her health emerged after she received her second jab earlier this year. The royal has been recovering at home for almost a month.
‘The Princess has been unwell and has sought medical attention,’ a source told the Sun on Sunday. ‘It has been a worrying time for those around her. It has been difficult for those close to her to see her suffering. She’s really been through it.’
The AstraZeneca vaccine has come under scrutiny in Europe after being linked to a very small number of blood clot cases. A scientific review by UK medical regulator MHRA concluded in April that evidence of a link between the vaccine and rare blood clots ‘is stronger but more work is still needed’.
The risk of a serious blood clot from AstraZeneca jab has doubled in a fortnight, new data show. Cases have gone up from 79 to 168 and deaths from 19 to 32. The chance of having a clot following vaccination has gone from one in 250,000 to one in 126,582.
Seven people suffered from partial paralysis after receiving the Sinovac vaccine, a doctor from Chulalongkorn University said. Six of them were in Rayong and one at the Queen Savang Vadhana Memorial Hospital in Chon Buri’s Sri Racha district. Their conditions improved after doctors administered medication to dissolve blood clots.
The Centers for Disease Control and Prevention is recommending that people who experience certain new symptoms after receiving Johnson & Johnson’s Covid-19 vaccine seek immediate medical treatment. The symptoms include sudden, severe headache, backache, new neurological symptoms, severe abdominal pain, shortness of breath, leg swelling, tiny red spots on the skin, and new or easy bruising.
While Johnson & Johnson’s vaccine is still authorized, the pause gives scientists time to review data and determine whether the vaccine is actually linked to the blood clots and, if so, whether recommendations on who should receive it should change.
Denmark has received the first claim for compensation for a death caused by a special type of blood clot, which the authorities link with the Astrazeneca vaccine. The patient compensation scheme has received a total of 29 compensation applications from citizens who have received the Astrazeneca vaccine. A further eight cases concern the Pfizer vaccine. There are no claims for Moderna.
This is stated by Patienterstatningen, which handles cases of compensation for citizens who are affected by serious side effects from e.g. medicines.
New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get Pfizer/BioNTech’s vaccine. The agency’s findings come from a study published in the online journal JAMA. The data revealed that 75% of Moderna recipients reported side effects after getting one dose of the COVID-19 vaccine compared to 65% of the Pfizer/BioNTech recipients. Side effects included pain at the injection site, fatigue and headaches.
The Swedish Medical Products Agency has received almost six times as many reports of suspected side effects for Astra Zeneca’s vaccine, compared with the other two EU-approved vaccines Pfizer/Biontech and Moderna, in relation to the number of people vaccinated. By the end of March, the authority had received 14,275 reports – by then, 252,000 people in Sweden had received the Swedish-British vaccine. It will be a share of 5.7 percent. The corresponding figure for Pfizer / Biontech is 0.7 and for Moderna 0.9.
The EMA’s response, along with that of the World Health Organisation, is published below:
A Virginia man suffered a severe reaction after getting his COVID-19 vaccine and doctors believe it was a direct result of the shot.
Richard Terrell got the one-dose Johnson & Johnson vaccine earlier this month. He suffered a severe rash that spread over his entire body and turned his skin red. The 74-year-old was admitted to the hospital and spent five days at the VCU Medical Center.
“It all just happened so fast. My skin peeled off,” Terrell said as he looked down. “It’s still coming off on my hands now.”
First, as a precaution, Berlin and Munich suspended the vaccinations with AstraZeneca for under 60-year-olds. Now the Standing Vaccination Commission will probably change its age recommendations for the preparation.
According to a draft resolution, the Standing Vaccination Commission (Stiko) wants to change its recommendations for the use of AstraZeneca’s corona vaccine. The Stiko Corona vaccinations with AstraZeneca only recommend for women and men over 60 in Germany.
The Berlin clinics Charité and Vivantes had previously announced the vaccination ban with reference to cases of cerebral vein thrombosis. Charité spokeswoman Manuela Zingl said “From the Charité’s point of view, this step is necessary because further cerebral vein thromboses in women in Germany have become known in the meantime.”
Thirteen new adverse events, including four serious ones, have been reported among the over 9,200 people who had received their first dose of the AstraZeneca vaccine in Taiwan, as of Friday, according to the Central Epidemic Command Center, CNA reports.
Taiwan has recorded a total of 27 adverse events, including the newly reported 13 cases, since the roll-out of the vaccination began on Monday, CECC official Lo Yi-chun said Saturday.
This was the first time the CECC has reported serious adverse events since a nurse in New Taipei became the first person to experience a severe reaction after receiving the vaccine on Wednesday.
Canada’s National Advisory Committee on Immunization is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons, a person familiar with the matter told The Associated Press on Monday.
If you have not had serious side effects 14 days after taking the AstraZeneca vaccine, you are probably not in danger of getting the rare course of the disease, the National Institute of Public Health (FHI) believes.
“We think you are out of the danger (zone) after 14 days. Then, it is unlikely that anything will happen. But this is based on the information we have on five patients, so there is quite limited patient material,” infection control director Geir Bukholm at the FHI told newspaper VG.
“During December 14–23, 2020, monitoring by the Vaccine Adverse Event Reporting System detected 21 cases of anaphylaxis after administration of a reported 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million doses); 71% of these occurred within 15 minutes of vaccination.”